Philadelphia Chromosome

The Philadelphia Chromosome test is a cytogenetic analysis that detects the presence of the Philadelphia chromosome, a specific chromosomal abnormality formed by the exchange of genetic material between chromosomes 9 and 22. This genetic change results in the formation of the BCR-ABL1 fusion gene, which is commonly associated with certain blood cancers, particularly chronic myeloid leukaemia (CML). The test helps identify this characteristic chromosomal alteration and provides valuable information for the diagnosis and clinical evaluation of haematological malignancies.

Who should get this test done?

This test may be recommended for individuals who:

●     Have signs or laboratory findings suggestive of chronic myeloid leukaemia (CML).

●     Are being evaluated for certain types of acute leukaemia, including Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).

●     Have persistent abnormalities in blood cell counts that require cytogenetic investigation.

●     Need chromosomal analysis as part of the diagnosis or evaluation of a blood cancer.

●     Require further assessment based on clinical findings or bone marrow examination.

Why consider this test?

The Philadelphia Chromosome test plays an important role in identifying a well-recognised genetic abnormality linked to specific blood cancers. Detecting this chromosomal change helps healthcare professionals better understand the genetic basis of the disease and supports accurate classification of certain leukaemias. The information obtained from this test contributes to a comprehensive diagnostic work-up and assists clinicians in making informed decisions regarding further evaluation, disease monitoring, and treatment planning.

More Information

The Philadelphia chromosome is created when parts of chromosomes 9 and 22 exchange places, producing the BCR-ABL1 fusion gene. This fusion gene leads to the production of an abnormal protein that promotes uncontrolled growth of blood-forming cells. The test examines chromosomes from dividing cells to identify this characteristic genetic rearrangement and also provides details such as the number of cells analysed, cells karyotyped, and the final chromosomal pattern. It is an important component of cytogenetic evaluation in haematological disorders.

Other Names

●     Philadelphia Chromosome Analysis

●     Philadelphia Chromosome Karyotyping

●     Cytogenetic Analysis for Philadelphia Chromosome

●     Ph Chromosome Test

●     Philadelphia Chromosome Cytogenetic Test

●     t(9;22) Chromosome Analysis